#1890859
Is galar tógálach é an galar coróinvíris (COVID-19) arb é coróinvíreas nua-aimsithe is cúis leis.
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.
Is galar tógálach é an galar coróinvíris (COVID-19) arb é coróinvíreas nua-aimsithe is cúis leis.
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.
Coróinvíreas a bhaineann le Géarshiondróm trom riospráide (coróinvíreas a bhaineann le SARS);
Severe acute respiratory syndrome-related coronavirus (SARS-related coronavirus);
Coróinvíreas a bhaineann le siondróm riospráide an Mheánoirthir (coróinvíreas a bhaineann le MERS);
Middle East respiratory syndrome-related coronavirus (MERS-related coronavirus);
Coróinvíreas a bhaineann le Géarshiondróm trom riospráide (coróinvíreas a bhaineann le SARS);
Severe acute respiratory syndrome-related coronavirus (SARS-related coronavirus);
Coróinvíreas a bhaineann le siondróm riospráide an Mheánoirthir (coróinvíreas a bhaineann le MERS);
Middle East respiratory syndrome-related coronavirus (MERS-related coronavirus);
Coróinvíreas a bhaineann le Géarshiondróm trom riospráide (coróinvíreas a bhaineann le SARS);
Severe acute respiratory syndrome-related coronavirus (SARS-related coronavirus);
Coróinvíreas a bhaineann le siondróm riospráide an Mheánoirthir (coróinvíreas a bhaineann le MERS);
Middle East respiratory syndrome-related coronavirus (MERS-related coronavirus);
Coróinvíreas a bhaineann le Géarshiondróm trom riospráide (coróinvíreas a bhaineann le SARS);
Severe acute respiratory syndrome-related coronavirus (SARS-related coronavirus);
Coróinvíreas a bhaineann le siondróm riospráide an Mheánoirthir (coróinvíreas a bhaineann le MERS);
Middle East respiratory syndrome-related coronavirus (MERS-related coronavirus);
Is é atá i ngéarshiondróm trom riospráide, choróinvíreas-2 (SARS-CoV-2), arb é is cúis leis an ngalar coróinvíris, ar thug an Eagraíocht Dhomhanda Sláinte (EDS) COVID-19 air, tréithchineál nua coróinvíris nár aithníodh cheana sa duine.
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which causes the coronavirus disease named COVID-19 by the World Health Organization (WHO), is a new strain of coronavirus not previously identified in humans.
Is galar tógálach é galar coróinvíris (COVID-19) arb é coróinvíreas nua-aimsithe (SARS-CoV-2) is cúis leis.
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus (SARS-CoV-2).
Staid na paindéime maidir leis an bhfliú daonna agus maidir leis an gcoróinvíreas daonna
Pandemic situation with respect to human influenza and human coronavirus
FRA,Coronavirus pandemic in the EU-impact on Roma and Travellers [Paindéim Choróinvíris san Aontas-tionchar ar na Romaigh agus ar an Lucht Siúil], 2020.
FRA, Coronavirus pandemic in the EU-impact on Roma and Travellers, 2020.
an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas (CRII) agus an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas Plus (CRII+) agus an pacáiste REACT-EU.
the Coronavirus Response Investment Initiative (CRII), the Coronavirus Response Investment Initiative Plus (CRII+) and REACT-EU package.
https://ec.europa.eu/info/live-work-travel-eu/coronavirus‑response/public-health/eu-vaccines‑strategy_ga.
https://ec.europa.eu/info/live-work-travel-eu/coronavirus-response/public-health/eu-vaccines-strategy_en.
Is iad na figiúirí príomha maidir le méid na n-acmhainní a slógadh faoin Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas (CRII) agus an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas Plus (CRII+):
The headline figures on the volume of resources mobilised under the Coronavirus Response Investment Initiative (CRII) and the Coronavirus Response Investment Initiative Plus (CRII+):
Na figiúirí príomha () maidir le méid na n-acmhainní a slógadh faoin Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas agus an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas Plus, is mar a leanas atá siad:
The headline figures () on the volume of resources mobilised under the Coronavirus Response Investment Initiative and the Coronavirus Response Investment Initiative Plus are as follows:
De mhaolú ar Chaibidlí I, II, IIa agus III, i gcás ina n-aithneoidh an Eagraíocht Dhomhanda Sláinte nó an tAontas go cuí go bhfuil staid na paindéime ann i ndáil leis an bhfliú daonna nó leis an gcoróinvíreas daonna, faoi chreat Chinneadh Uimh. 1082/2013/AE ó Pharlaimint na hEorpa agus ón gComhairle, féadfaidh na húdaráis ábhartha, nó i gcás údaruithe margaíochta láraithe, féadfaidh an Coimisiún, i gcás ina bhfuil sonraí cógaisíochta, neamhchliniciúla nó cliniciúla in easnamh, glacadh go heisceachtúil agus go sealadach le hathrú ar na téarmaí a bhaineann le húdarú margaíochta le haghaidh vacsaín fhliú dhaonna nó vacsaín choróinvíris dhaonna.
By way of derogation from Chapters I, II, IIa and III, where a pandemic situation with respect to human influenza or human coronavirus is duly recognised by the World Health Organization or by the Union in the framework of Decision No 1082/2013/EU of the European Parliament and of the Council, the relevant authorities, or in the case of centralised marketing authorisations, the Commission may, where certain pharmaceutical, non-clinical or clinical data are missing, exceptionally and temporarily accept a variation to the terms of a marketing authorisation for a human influenza vaccine or a human coronavirus vaccine.
An 30 Eanáir 2020, d’fhógair Ard-Stiúrthóir na hEagraíochta Domhanda Sláinte (EDS) éigeandáil sláinte poiblí arb ábhar imní idirnáisiúnta í i ngeall ar an ráig dhomhanda de ghéarshiondróm trom riospráide, coróinvíreas 2 (SARS-CoV-2), arb é is cúis le galar choróinvíreas 2019 (COVID-19).
On 30 January 2020, the Director-General of the World Health Organization (WHO) declared a public health emergency of international concern over the global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19).
An 30 Eanáir 2020, d’fhógair Ard-Stiúrthóir na hEagraíochta Domhanda Sláinte (EDS) éigeandáil sláinte poiblí arb ábhar imní idirnáisiúnta í i ngeall ar an ráig dhomhanda de choróinvíreas géarshiondróim throm riospráide 2 (SARS-CoV-2), arb é is cúis le galar an choróinvíris 2019 (COVID-19).
On 30 January 2020, the Director-General of the World Health Organization (WHO) declared a public health emergency of international concern over the global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19).
Ag tús ghéarchéim COVID-19, le cistí comhtháthaithe soláthraíodh freagairt thapa faoin Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas agus faoin Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas Plus (CRII agus CRII+), rud a chuir le méadú glan ó cháin os cionn EUR 11 billiún le haghaidh bearta fostaíochta agus bearta cúraim sláinte faoi mhí na Samhna 2021.
At the start of the COVID-19 crisis, cohesion funds provided a rapid response under the Coronavirus Response Investment Initiative and the Coronavirus Response Investment Initiative Plus (CRII and CRII+), resulting in a net increase of over EUR 11 billion for employment and healthcare measures by November 2021.
An 30 Eanáir 2020, d’fhógair Ard-Stiúrthóir na hEagraíochta Domhanda Sláinte (EDS) éigeandáil sláinte poiblí arb ábhar imní idirnáisiúnta í i ngeall ar an ráig dhomhanda de choróinvíreas nua, arb é is cúis le galar choróinvíreas 2019 (COVID-19).
On 30 January 2020, the Director-General of the World Health Organization (WHO) declared a public health emergency of international concern over the global outbreak of novel coronavirus, which causes Coronavirus disease 2019 (COVID-19).
An 30 Eanáir 2020, d’fhógair Ard-Stiúrthóir na hEagraíochta Domhanda Sláinte éigeandáil sláinte poiblí arb ábhar imní idirnáisiúnta í i ngeall ar an ráig dhomhanda den choróinvíreas nua, atá ina cúis le galar Choróinvíreas 2019 (COVID-19).
On 30 January 2020, the Director-General of the World Health Organization (WHO) declared a public health emergency of international concern over the global outbreak of novel coronavirus, which causes Coronavirus disease 2019 (COVID-19).
In 2022, lean na Ballstáit d’úsáid a bhaint as an tsolúbthacht a mhol an Coimisiún in 2020 chun raon feidhme na gníomhaíochta a leathnú ionas go mbeadh bearta lena dtabharfaí tacaíocht don fhreagairt sláinte poiblí sna Ballstáit incháilithe freisin, agus chun athchlárú a spreagadh in earnálacha eile dá ngeilleagair, ach solúbthacht eisceachtúil á soláthar i gcomhthráth i ndáil leis na cistí ón mbeartas comhtháthaithe a úsáid faoin Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas agus faoin Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas Plus.
In 2022, Member States continued to use the flexibilities proposed by the Commission in 2020 to broaden the scope of action so that measures supporting the public health response in Member States are also eligible, and to encourage reprogramming in other sectors of their economy, while providing exceptional flexibility for the use of the cohesion policy funds under the Coronavirus Response Investment Initiative and the Coronavirus Response Investment Initiative Plus.
Go foriomlán, tá 239 leasú ar na cláir bheartais comhtháthaithe atá ann cheana iarrtha ag 25 Bhallstát agus ag an Ríocht Aontaithe ag úsáid an tsolúbthacht a thairgtear leis an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas agus an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas Plus ().
In all, 25 Member States and the United Kingdom have requested 239 amendments to their existing cohesion policy programmes using the flexibilities offered by the Coronavirus Response Investment Initiative and the Coronavirus Response Investment Initiative Plus ().
Comhlánaíodh na bearta freagartha géarchéime agus réitigh géarchéime faoin Tionscnamh Infheistíochta um an bhFreagairt ar an gCoróinvíreas agus faoin Tionscnamh Infheistíochta um an bhFreagairt ar an gCoróinvíreas Plus le hiomlán de EUR 50.6 billiún faoin gcúnamh téarnaimh le haghaidh comhtháthú agus críocha na hEorpa (REACT-EU) chun tacú le hinniúlachtaí réitigh géarchéime, lena n-áirítear bearta fostaíochta, tacaíocht do chórais chúram sláinte agus d’fhiontair bheaga agus mheánmhéide agus chun téarnamh glas, digiteach agus athléimneach an gheilleagair a ullmhú, mar shampla trí infheistíochtaí a dhéanamh in éifeachtúlacht fuinnimh, glasú uirbeach agus digitiú scoileanna agus gnólachtaí.
The crisis-response and crisis-repair measures under Coronavirus Response Investment Initiative and Coronavirus Response Investment Initiative Plus were complemented by a total of EUR 50.6 billion under the recovery assistance for cohesion and the territories of Europe (REACT-EU) to support crisis-repair capacities, including employment measures, support to healthcare systems and small and medium-sized enterprises and prepare the green, digital and resilient recovery of the economy, for example, through investments in energy efficiency, urban greening and digitalisation of schools and businesses.
Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas agus Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas Plus, a forlíonadh i mí Bealtaine 2020 le pacáiste an Chúnaimh Téarnaimh don Chomhtháthú agus do Chríocha na hEorpa (REACT-EU) chun tacú le hinniúlachtaí réitigh géarchéime, lena n-áirítear bearta fostaíochta, tacaíocht do chórais cúraim sláinte agus d’fhiontair bheaga agus mheánmhéide agus chun téarnamh glas, digiteach agus athléimneach an gheilleagair a ullmhú.
the Coronavirus Response Investment Initiative and the Coronavirus Response Investment Initiative Plus, which were supplemented in May 2020 with the Recovery Assistance for Cohesion and the Territories of Europe (REACT-EU) package to support crisis-repair capacities, including employment measures, support to healthcare systems and small and medium-sized enterprises and prepare the green, digital and resilient recovery of the economy.
Go foriomlán, tá 239 leasú ar na cláir bheartais comhtháthaithe atá acu cheana iarrtha ag 25 Bhallstát agus ag an Ríocht Aontaithe ag úsáid an tsolúbthacht a thairgtear leis an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas agus an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas Plus.
25 Member States and the United Kingdom have requested 239 amendments to their existing cohesion policy programmes using the flexibilities offered by the Coronavirus Response Investment Initiative and the Coronavirus Response Investment Initiative Plus.
a bhaineann le táirgí íocshláinte lena n‐úsáid ag an duine ina bhfuil orgánaigh ghéinmhodhnaithe atá beartaithe an galar coróinvíris (COVID-19) a chóireáil nó a chosc nó atá comhdhéanta díobh agus soláthar na dtáirgí sin
on the conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or prevent coronavirus disease (COVID-19)
An 11 Márta 2020, dhearbhaigh an Eagraíocht Dhomhanda Sláinte (EDS) gur paindéim dhomhanda a bhí i ráig an choróinvíris úrnua (COVID-19).
On 11 March 2020, the World Health Organization (WHO) declared the novel coronavirus (COVID-19) outbreak a global pandemic.
D’fhéadfaí na hoibríochtaí seo a fhorfheidhmiú freisin trí mhodh cianda nuair a ghearrtar srianta nó moltaí arna n-eisiúint ag údaráis inniúla chun moill a chur le scaipeadh an choróinvíris.
These operations may also be implemented by remote means when restrictions are imposed or recommendations issued by competent authorities to delay the spread of the coronavirus.
De réir an chur chuige a ghlactar i leith vacsaíní in aghaidh an fhliú dhaonna, ba cheart feidhm a bheith ag na nósanna imeachta le gach vacsaín in aghaidh an choróinvíris dhaonna agus ba cheart cloí le hamchlár brostaithe.
In line with the approach taken with human influenza vaccines, the procedures should apply to all human coronavirus vaccines and follow an accelerated timetable.
séiritíopa, tréithchineál, antaigin nó seicheamh códúcháin nó meascán de sheiritíopaí, de thréithchineálacha, d’antaiginí nó de sheichimh chódúcháin a ionadú i vacsaín choróinvíreas dhaonna nó a chur léi;
replacement or addition of a serotype, strain, antigen or coding sequence or combination of serotypes, strains, antigens or coding sequences for a human coronavirus vaccine;
athruithe a bhaineann le séiritíopa, tréithchineál, antaigin nó seicheamh códúcháin nó meascán de sheiritíopaí, de thréithchineálacha, d’antaiginí nó de sheichimh chódúcháin a ionadú sa vacsaín choróinvíreas dhaonna nó a chur léi.”
variations related to the replacement or addition of a serotype, strain, antigen or coding sequence or combination of serotypes, strains, antigens or coding sequences for a human coronavirus vaccine.’
Arna thacú le Tionscnaimh Infheistíochta mar Fhreagairt ar an gCoróinvíreas (CRII agus CRII+), sholáthair an Phortaingéil trealamh TF do scoláirí faoi mhíbhuntáiste agus oiliúint in inniúlachtaí digiteacha do mhúinteoirí.
Supported by the Coronavirus Response Investment Initiatives (CRII and CRII+), Portugal has provided IT equipment to disadvantaged students and training in digital competences for teachers.
Sa tSlóivéin bhí tacaíocht do sholáthraithe na foghlama aosaigh mar chuid de dhlí (an ‘5ú pacáiste coróinvíris) le freagairt don phaindéim.
In Slovenia support to adult learning providers was part of a law (the ‘5th coronavirus package’) to respond to the pandemic.
An 11 Márta 2020, d’fhógair an Eagraíocht Dhomhanda Sláinte (EDS) go bhféadfaí ráig ghalar an choróinvíris (COVID-19) a shaintréithriú feasta mar phaindéim.
On 11 March 2020, the World Health Organization (WHO) declared that the outbreak of the coronavirus disease (COVID-19) could henceforth be characterised as a pandemic.
An 11 Márta 2020, d’fhógair an Eagraíocht Dhomhanda Sláinte (EDS) go bhféadfaí ráig ghalar an choróinvíris (COVID-19) a shaintréithriú feasta mar phaindéim.
On 11 March 2020, the World Health Organization (WHO) declared that the outbreak of the coronavirus disease (COVID-19) could henceforth be characterised as a pandemic.
Is í an tSaoráid Téarnaimh agus Athléimneachta, a bunaíodh le Rialachán (AE) 2021/241 an 19 Feabhra 2021, an mhír lárnach de ‘Next Generation EU’, agus is é freagairt an Aontais Eorpaigh chun teacht as paindéim an choróinvíris agus a bheith níos láidre ná riamh.
The Recovery and Resilience Facility, established by Regulation (EU) 2021/241 on 19 February 2021, is the centrepiece of “Next Generation EU”, the EU response to emerge stronger from the coronavirus pandemic.
Ar fáil ar: https://ec.europa.eu/info/live-work-travel-eu/coronavirus-response/public-health/high-quality-covid-19-testing_en
Available at: https://ec.europa.eu/info/live-work-travel-eu/coronavirus-response/public-health/high-quality-covid-19-testing_en
In 2021, shlóg an Coimisiún freisin EUR 123 mhilliún le haghaidh taighde ar athraithigh den choróinvíreas mar a fógraíodh i mí Aibreáin agus i gcomhréir le gorlann HERA.
In 2021, the Commission also mobilised EUR 123 million for research on coronavirus variants as announced in April and in line with the HERA incubator.
Aithníodh go sealadach san anailís na fionnachtana is tábhachtaí ar chuir cistiú T&N an Aontais leo, chomh maith le taighde ar ráigeanna an choróinvíris roimhe seo ar a mbunaítear an comhrac in aghaidh na paindéime reatha.
The analysis tentatively identified the most important discoveries to which EU R&I funding has contributed, as well as research on past coronavirus outbreaks on which the fight against the current pandemic builds.
Leis an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas, a bunaíodh in 2020, bhíothas in ann leas iomlán solúbtha a bhaint as na cistí uile a bhí fágtha i gcláir beartais chomhtháthaithe 2014-2020.
The Coronavirus Response Investment Initiatives, established in 2020, allowed the fully flexible mobilisation of all the remaining funds in the 2014-2020 cohesion policy programmes.
Agus é ag pleanáil don mheántéarma, tá an Coimisiún ag dul i gcomhar le comhpháirtithe idirnáisiúnta agus le forbróirí vacsaíní uilechoróinvíris a d’fhéadfadh a bheith ann, nó comhvacsaíní a spreagann freagairtí imdhíonachta níos leithne, níos láidre agus níos buaine.
Planning for the medium-term, the Commission is engaging with international partners and developers of potential pan-coronavirus, or combination vaccines that elicit broader, stronger, and longer-lasting immune responses.
Leis na bearta spriocdhírithe tacaíochta fostaíochta in earnálacha íogaire, bhí fostóirí in ann fostaithe a choinneáil tar éis ghéarchéim an choróinvíris agus déantar éascaíocht do théarnamh an gheilleagair.
The targeted employment support measures in sensitive sectors have allowed employers to retain employees following the outbreak of the coronavirus crisis and facilitate the recovery of the economy.
Is éard atá sa dá scéim ‘Gefyra’ scéimeanna sealadacha maidir le fóirdheontais tráthchodanna arna mbunú ag na húdaráis le haghaidh féichiúnaithe tuillmheacha nó féichiúnaithe athstruchtúraithe a ndearna an coróinvíreas difear dóibh.
The two “Gefyra” schemes are temporary instalment subsidy schemes set up by the authorities for performing or restructured coronavirus-affected debtors.
Chuir an Tionscnamh Infheistíochta mar Fhreagairt ar an gCoróinvíreas()an chéad chúnamh éigeandála ón Aontas Eorpach ar fáil d’Éirinn maidir le paindéim COVID-19.
The Coronavirus Response Investment Initiative () provided the first EU emergency assistance to Ireland in relation to the COVID-19 pandemic.
ina theannta sin, úsáideann an Phortaingéil an Eagraíocht Eitlíochta Sibhialta Idirnáisiúnta (ICAO - Effects of Novel Coronavirus (COVID-19) on Civil Aviation: Economic Impact Analysis, Montréal, Ceanada, 12 Eanáir 2022).
in addition, Portugal uses International Civil Aviation Organization (ICAO - Effects of Novel Coronavirus (COVID-19) on Civil Aviation: Economic Impact Analysis, Montréal, Canada 12 January 2022).
maolú ar an gcreat rialála lena n-áirítear na Tionscnaimh Infheistíochta mar Fhreagairt ar an gCoróinvíreas (CRII agus CRII +), an creat státchabhrach agus gníomhachtú an chlásail éalaithe ghinearálta le haghaidh beartas fioscach;
a relaxation of the regulatory framework including the Coronavirus Response Investment Initiatives (CRII and CRII+), the state aid framework and the activation of the general escape clause for fiscal policy;
Athbhreithniú comparáideach ar impleachtaí socheacnamaíocha na paindéime coróinvíris (COVID-19) sna Stáit Bhaltacha.
A comparative review of socio-economic implications of the coronavirus pandemic (COVID-19) in the Baltic States.